PCT/2001/50 - World Intellectual Property Organization
PCT/2001/50 - World Intellectual Property Organization
PCT/2001/50 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>50</strong>/<strong>2001</strong><br />
13 Dec/déc <strong>2001</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 22879<br />
TJ TM TR TT TZ UA UG UZ VN YU ZA<br />
ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 C07C 311/05, A61K 31/18, A61P 25/18,<br />
25/28<br />
(11) WO 01/94306 (13) A2<br />
(21) <strong>PCT</strong>/US01/10829<br />
(22) 23 May/mai <strong>2001</strong> (23.05.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/209,675 6 Jun/juin 2000 US<br />
(06.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) • (BIS)SULFONAMIDE DERIVATIVES<br />
• DERIVES DE (BIS)SULFONAMIDE<br />
(71) ELI LILLY AND COMPANY [US/US];<br />
Lilly Corporate Center, Indianapolis, IN<br />
46285 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) KNOBELSDORF, James, Allen<br />
[US/US]; 10182 Parkshore Drive, Noblesville,<br />
IN 46060 (US). ZARRINMAYEH,<br />
Hamideh [US/US]; 924 Sable Run, Carmel,<br />
IN 46032 (US).<br />
(74) LENTZ, Nelsen, L. et al. / etc.; Eli Lilly and<br />
Company, Lilly Corporate Center, Indianapolis,<br />
IN 46285 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT TZ UA UG<br />
US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 C07C 311/08, C07D 295/18, A61K 31/216,<br />
31/4965, A61P 13/00, 1/00<br />
(11) WO 01/94307 (13) A1<br />
(21) <strong>PCT</strong>/FR01/01652<br />
(22) 29 May/mai <strong>2001</strong> (29.05.<strong>2001</strong>)<br />
(25) fr (26) fr<br />
(30) 00/07190 6 Jun/juin 2000 FR<br />
(06.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) • PROPANOLAMINOTETRALINES,<br />
PREPARATION THEREOF AND COM-<br />
POSITIONS CONTAINING SAME<br />
• PROPANOLAMINOTETRALINES,<br />
LEUR PREPARATION ET COMPO-<br />
SITIONS PHARMACEUTIQUES EN<br />
CONTENANT<br />
(71) SANOFI-SYNTHELABO [FR/FR]; 174,<br />
avenue de France, F-7<strong>50</strong>13 Paris (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BARZAGHI, Laura [IT/IT]; Via Aguggiari<br />
18, I-20052 Monza (IT). BOVY,<br />
Philippe, R. [BE/FR]; 13, rue du 4 Septembre,<br />
F-787<strong>50</strong> Mareil Marly (FR). CECCHI,<br />
Roberto [IT/IT]; Piazza P. Gobetti, 1D,<br />
I-26900 Lodi (IT). CROCI, Tiziano [IT/IT];<br />
Via Cucchiari, 25, I-20156 Milano (IT). RO-<br />
MAGNANO, Stefano [IT/IT]; Via Scarlatti<br />
33, I-20090 Buccinasco (IT).<br />
(74) VARADY, Peter; Sanofi-Synthelabo, 174,<br />
avenue de France, F-7<strong>50</strong>13 Paris (FR).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT TZ UA UG<br />
US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 C07D 201/16<br />
(11) WO 01/94308<br />
(21) <strong>PCT</strong>/EP01/06310<br />
(13) A1<br />
(22) 2 Jun/juin <strong>2001</strong> (02.06.<strong>2001</strong>)<br />
(25) de (26) de<br />
(30) 100 27 328.9 5 Jun/juin 2000<br />
(05.06.2000)<br />
DE<br />
(30) 100 33 516.0 11 Jul/juil 2000<br />
(11.07.2000)<br />
DE<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) • METHOD FOR SEPARATING AMMO-<br />
NIA FROM SOLUTIONS CONTAINING<br />
CAPROLACTAM AND AMMONIA<br />
• VERFAHREN ZUR ABTRENNUNG<br />
VON AMMONIAK AUS LOSUNGEN,<br />
DIE CAPROLACTAM<br />
NIAK ENTHALTEN<br />
UND AMMO-<br />
(71) BASF AKTIENGESELLSCHAFT<br />
[DE/DE]; 67056 Ludwigshafen (DE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) LUYKEN, Hermann [DE/DE]; Brüsseler<br />
Ring 34, 67069 Ludwigshafen (DE).<br />
OHLBACH, Frank [DE/DE]; Erftstrasse<br />
28, 40219 Düsseldorf (DE). MAIXNER,<br />
Stefan [DE/DE]; Königsäcker 53, 68723<br />
Schwetzingen (DE). FISCHER, Rolf-Hartmuth<br />
[DE/DE]; Bergstr. 98, 69121 Heidelberg<br />
(DE). MELDER, Johann-Peter<br />
[DE/DE]; Fichtenstrasse 2, 67459<br />
Böhl-Iggelheim (DE). BASSLER, Peter<br />
[DE/DE]; Maria-Mandel-Str. 18, 68519<br />
Viernheim (DE). ANSMANN, Andreas<br />
[DE/DE]; Im Köpfle 6,<br />
(DE).<br />
69168 Wiesloch<br />
(74) BASF AKTIENGESELLSCHAFT; 67056<br />
Ludwigshafen (DE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT TZ UA UG<br />
US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 C07D 207/32, 207/327, 209/08, 277/46,<br />
277/<strong>50</strong>, 333/40, 213/75, 405/04, 405/12,<br />
277/46, 333/34, 409/06, 409/14<br />
(11) WO 01/94309 (13) A1<br />
(21) <strong>PCT</strong>/JP01/04430<br />
(22) 28 May/mai <strong>2001</strong> (28.05.<strong>2001</strong>)<br />
(25) ja (26) ja<br />
(30) 2000-166305 2 Jun/juin 2000 JP<br />
(02.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) • DRUG COMPOSITION ANTAGONIS-<br />
TIC TO BOTH PGD2/TXA2 RECEPTORS<br />
• COMPOSITION MEDICAMENTEUSE<br />
ANTAGONISTE POUR LES RECEP-<br />
TEURS DE PGD2/TXA2<br />
(71) SHIONOGI & CO., LTD. [JP/JP]; 1-8,<br />
Doshomachi 3-chome, Chuo-ku, Osaka-shi,<br />
Osaka 541-0045 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) TANIMOTO, Norihiko [JP/JP]; c/o<br />
Shionogi & Co., Ltd., 12-4, Sagisu 5-chome,<br />
Fukushima-ku, Osaka-shi, Osaka 553-0002<br />
(JP). ARIMURA, Akinori [JP/JP]; c/o Shionogi<br />
& Co., Ltd., 1-1, Futabacho 3-chome,<br />
Toyonaka-shi, Osaka 561-0825 (JP).<br />
(74) YAMAUCHI, Hideaki et al. / etc.; Shionogi<br />
& Co., Ltd. <strong>Intellectual</strong> <strong>Property</strong> Department,<br />
12-4, Sagisu 5-chome, Fukushima-ku, Osakashi,<br />
Osaka 553-0002 (JP).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ VN<br />
YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 C07D 209/12<br />
(11) WO 01/94310<br />
(21) <strong>PCT</strong>/US01/18584<br />
(13) A1<br />
(22) 7 Jun/juin <strong>2001</strong> (07.06.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/210,145 7 Jun/juin 2000<br />
(07.06.2000)<br />
US<br />
(30) 60/221,277 27 Jul/juil 2000<br />
(27.07.2000)<br />
US<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) • METHODS FOR MAKING BIS-HETE-<br />
ROCYCLIC ALKALOIDS<br />
• PROCEDES DE FABRICATION D’AL-<br />
CALOIDES BIS-HETEROCYCLIQUES<br />
(71) THE STATE OF OREGON ACTING BY<br />
AND THROUGH THE STATE BOARD